HAVISHAKRISHNA SARMA: Open Payments
NPI 1992934020 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 23 payments from 10 companies in 2025. Trend: 2023 $702 · 2024 $711 · 2025 $584
Food & beverage: $544Education: $40
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $226 |
| ABBVIE INC. | 4 | $118 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Orexo US, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $13 |
Products named: FANAPT, REXULTI, Kerendia, LINZESS, Zubsolv, AVYCAZ, EMBLAVEO, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
